Skip to main content
SpringerLink
Log in

Liver Tumor Promotion and Breast Cancer Chemoprevention: Common Mechanisms

  • Conference paper
Nongenotoxic Carcinogenesis

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 10))

  • 34 Accesses

Abstract

Carcinogenesis has been operationally divided into three stages (Fig. 1) (Dragan and Pitot 1992). The first stage is initiation, which involves an irreversible genetic change that occurs in cells either spontaneously or upon exposure to chemical and physical agents. The reversible process of promotion, the second stage of neoplastic development, selectively expands the number of these initiated cells. The final stage of tumor development is progression. It entails the accumulation of additional genetic lesions that result in the activation of oncogenes and/or the inactivation of tumor suppressor genes (Vogelstein and Kinzler 1993). It is during this latter stage of tumor development that hepatocellular carcinomas are observed forming within benign adenomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abanobi SE, Lombardi B, Shinozuka H (1982) Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline-devoid diet and their suppression by phenobarbital. Cancer Res 42: 412–415

    PubMed  CAS  Google Scholar 

  • Barbason H, Rassenfosse C, Betz EH (1983) Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect. Br J Cancer 47: 517–525

    Article  PubMed  CAS  Google Scholar 

  • Barlow DP, Stöger R, Herrmann BG, Saito K, Schweifer N (1991) The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349: 84–87

    Article  PubMed  CAS  Google Scholar 

  • Border WA, Ruoslahti E (1992) Transforming growth factor-6 in disease: the dark side of tissue repair. J Clin Invest 90: 1–7

    Article  PubMed  CAS  Google Scholar 

  • Brockenbrough JS, Meyer SA, Li C, Jirtle RL (1991) A reversible and phorbol ester-specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats. Cancer Res 51: 130–136

    PubMed  CAS  Google Scholar 

  • Butta A, MacLennan K, Flanders KC, Sacks NPM, Smith I, McKinna A, Dowsett M, Wakefield LM, Sporn MB, Baum N, Colletta AA (1992) Induction of transforming growth factor (31 in human breast cancer in vivo following tamoxifen treatment. Cancer Res 52: 4261–4264

    PubMed  CAS  Google Scholar 

  • Chen R-H, Ebner R, Derynck R (1993) Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-(3 activities. Science 260: 1335–1338

    Article  PubMed  CAS  Google Scholar 

  • Couce ME, Weatherington AJ, McGinty JF (1992) Expression of insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptor in the rat hippocampus: an in situ hybridization and immunocytochemical study. Endocrinology 131: 1636–1642

    Article  PubMed  CAS  Google Scholar 

  • Crowell PL, Chang RR, Ren Z, Elson CE, Gould MN (1991) Selective inhibition of isoprenylation of 21–26 kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266: 17679–17685

    PubMed  CAS  Google Scholar 

  • Daughaday WH (1990) The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127: 1–4 (editorial)

    Google Scholar 

  • Dennis PA, Rifkin DB (1991) Cellular activation of latent transforming growth factor ß requires binding to the cation-independent mannose 6phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88: 580–584

    Article  PubMed  CAS  Google Scholar 

  • Dragan YP, Pitot HC (1992) The role of the stages of initiation and promotion in phenotypic diversity during hepatocarcinogenesis. Carcinogenesis 5: 739–750

    Article  Google Scholar 

  • Ebner R, Chen R-H, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R (1993) Cloning of a type I TGF-13 receptor and its effect on TGF-13 binding to the type II receptor. Science 260: 1344–1348

    Article  PubMed  CAS  Google Scholar 

  • Elegbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN (1984) Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis 5: 661–664

    Article  PubMed  CAS  Google Scholar 

  • Haag JD, Lindstrom MJ, Gould MN (1992) Limonene-induced regression of mammary carcinomas. Cancer Res 52: 4021–4026

    PubMed  CAS  Google Scholar 

  • Haig D, Graham C (1991) Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64: 1045–1046

    Article  PubMed  CAS  Google Scholar 

  • Jirtle RL, Meyer SA (1991) Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-131 expression. Dig Dis Sci 36: 659–668

    Article  PubMed  CAS  Google Scholar 

  • Jirtle RL, Meyer SA, Brockenbrough JS (1991) Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. In: Butterworth BE, Slaga TJ, Farland W, McClain M (eds) Chemically induced cell proliferation implications for risk assessment. Wiley-Liss, New York, pp 209–216

    Google Scholar 

  • Jirtle RL, Haag JD, Ariazi EA, Gould MN (1993) Increased mannose 6-phosphate/insulin-like growth factor II receptor and TGF-(31 levels during monoterpene-induced regression of mammary tumors. Cancer Res 53: 3894–3852

    Google Scholar 

  • Jirtle RL, Hankins GR, Reisenbichler H, Boyer IJ (1994) Regulation of man-nose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbitol. Carcinogenesis 15: (in press)

    Google Scholar 

  • Kapkaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin C-H (1990) TGF-131 binding protein: a component of the large latent complex of TGF-131 with multiple repeat sequences. Cell 61: 1051–1061

    Article  Google Scholar 

  • Kojima S, Nara K, Rifkin DB (1993) Requirement for transglutaminase in the activation of latent transforming growth factor-13 in bovine endothelial cells. J Cell Biol 121: 439–448

    Article  PubMed  CAS  Google Scholar 

  • Kornfeld S (1992) Structure and function of the mannose 6-phosphate/insulin like growth factor II receptors. Annu Rev Biochem 61: 307–330

    Article  PubMed  CAS  Google Scholar 

  • Kovacina KS, Steele-Perkins G, Purchio AF, Lioubin M, Miyazono K, Heldin C-H, Roth RA (1989) Interactions of recombinant and platelet transforming growth factor-f31 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem Biophys Res Commun 160: 393–403

    Article  PubMed  CAS  Google Scholar 

  • Laureys G, Barton DE, Ullrich A, Francke U (1988) Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-independent mannose 6-phosphate receptor in man and mouse. Genomics 3: 224–229

    Article  PubMed  CAS  Google Scholar 

  • Lin HY, Wang X-F, Hg-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-ß type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785

    Article  PubMed  CAS  Google Scholar 

  • Lopez-Cassillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-13 receptor system. Cell 67: 785–795

    Article  Google Scholar 

  • Lopez-Casillas F, Wrana JL, Massagué J (1993) Betaglycan presents ligand to the TGF-ß signaling receptor. Cell 73: 1435–1444

    Article  PubMed  CAS  Google Scholar 

  • Massague J (1990) The transforming growth factor-13 family. Annu Rev Cell Biol 6: 597–641

    Article  PubMed  CAS  Google Scholar 

  • McLean AE, Driver HE, Sutherland IA (1992) Liver tumour promotion by phenobarbital: comparison of rat and human studies. Prog Clin Biol Res 374: 251–259

    PubMed  CAS  Google Scholar 

  • Nissley P, Lopaczynski W (1991) Insulin-like growth factor receptors. Growth Factors 5: 29–43

    Article  PubMed  CAS  Google Scholar 

  • Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engström U, Heldin C-H (1992) Transforming growth factor-ß1, 132, and 133 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 267: 19482–19488

    Google Scholar 

  • Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SAW, Ramasharma K, Marshall M, Li CH (1989) Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3: 1701–1709

    Article  PubMed  CAS  Google Scholar 

  • Peraino C, Fry RJM, Staffeldt E (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res 31: 1506–1512

    PubMed  CAS  Google Scholar 

  • Peraino C, Fry RJM, Staffeldt E, Christopher JP (1975) Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic turnorigenesis in the rat. Cancer Res 35: 2884–2890

    PubMed  CAS  Google Scholar 

  • Preat V, Lans M, de Gerlache J, Taper H, Roberfroid M (1987) Influence of the duration and the delay of administration of phenobarbital on its modulating effect on rat hepatocarcinogenesis. Carcinogenesis 8: 333–335

    Article  PubMed  CAS  Google Scholar 

  • Schlunegger MP, Grütter MG (1992) An unusual structural feature revealed by the 2.2 a resolution crystal structure of human transforming growth factor-f32. Nature 358: 430–434

    Article  PubMed  CAS  Google Scholar 

  • Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J (1986) Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer. Carcinogenesis 7: 1651–1655

    Article  PubMed  CAS  Google Scholar 

  • Sklar MM, Thomas CL, Municchi G, Roberts CT Jr, LeRoith D, Kiess W, Nissley P (1992) Developmental expression of rat insulin-like growth factor-IUmannose 6-phosphate receptor messenger ribonucleic acid. Endocrinology 130: 3484–3491

    Article  PubMed  CAS  Google Scholar 

  • Solt D, Farber E (1976) New principle for the analysis of chemical carcinogenesis. Nature 263: 701–703

    Article  CAS  Google Scholar 

  • Stöger R, Kubicka P, Liu C-G, Kafri T, Razin A, Cedar H, Barlow DP (1993) Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73: 61–71

    Article  PubMed  Google Scholar 

  • Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 4: 138–141

    Article  Google Scholar 

  • Wang X-F, Lin HY, Hg-Eaton E, Downward J, Lodish HF, Weinberg RA (1991) Expression cloning and characterization of the TGF-13 type III receptor. Cell 67: 797–805

    Article  PubMed  CAS  Google Scholar 

  • Yager JD, Roebuck BD, Paluszcyk TL, Memoli VA (1986) Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis 7: 2007–2014

    Article  PubMed  CAS  Google Scholar 

  • Yang D, Rogler CE (1991) Analysis of insulin-like growth factor II ( IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry. Carcinogenesis 12: 1893–1901

    Google Scholar 

Download references

Authors
  1. R. L. Jirtle
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Andrew Cockburn Lewis Smith

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Jirtle, R.L. (1994). Liver Tumor Promotion and Breast Cancer Chemoprevention: Common Mechanisms. In: Cockburn, A., Smith, L. (eds) Nongenotoxic Carcinogenesis. Ernst Schering Research Foundation Workshop, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03022-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-03022-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-03024-0

  • Online ISBN: 978-3-662-03022-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation